Merete Ellekilde-Pedersen

Merete Ellekilde-Pedersen is an experienced clinical research professional with a robust academic and practical background in pharmacology and veterinary medicine. Currently serving as Associate Director and Clinical Research Scientist at Genmab since March 2018, Merete has previously held senior roles in clinical research at the same company and at Novo Nordisk, focusing on managing clinical trials and pharmacology. Merete's academic credentials include a PhD in in vivo pharmacology from Københavns Universitet and a BSc and MSc in veterinary medicine from Den Kgl. Veterinær- og Landbohøjskole. Notably, Merete's doctoral research investigated the impact of gut microbiota on glucose intolerance, leading to multiple international presentations. Additionally, Merete participated in early research at Michigan State University as a summer research scholar, contributing to a published study on anti-inflammatory proteins.